Icon
+91 94997 68112
Login Register

Fenoglide - (40,120 mg; Tablet, Oral)

Fenofibrate SALIX Pharma
40,120 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
Less Than 5
Adjunct to diet in hypertriglyceridemia and to reduce elevated LDL-C, total-C, TG, and apo B, and to increase HDL-C, in primary hyperlipidemia and mixed dyslipidemia. Limitation of Use: was not shown to reduce coronary heart disease morbidity and mortality in patients with type 2 diabetes.
Yes
** **** *********** ******** ** **** *** *** *** *** **** *** ***** *** ******* ****** **********. ****** ********* *** ****** ****, *** ****** *** *** **** *********** ** ******** *** ******. **** ** ******* **** *** ****** ***** ***** ** ~** *** ********* ********** ******** **** **** ~$****. ** **** ** **** **** ** ******** ***** *** ****** *** *********, *** ****** **** *** ** ***********, ******** **-****** **** **** ***** **** ****** ** **** ****.
Fenoglide Patent 1 Patent 2 Patent 3 Patent 4
***** ******* ******* ******* *******
***** ******* ******* ******* *******
********* ****** *** ********* *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ** *** **** ******* **** ****** **** ********
***** ** \ ** *** **, **** ******* ******** ******** ** *** **, ****
********* ****** ** \ ** ** *** ********* ******** ******** ** **** **, ****
  1. ***** **** : ***** ******** ******** ***** *** ****** **** ********* *** ****** '***.
  2. ***** **** : ******** ***** * **** ******* ***** ** ******** ***** ** ********.
  3. ***, **** : ***** ***** **** **** **** ** ** **** *** ******* ******* ** ********* **** *** ***** ******* ****** ********** ** ******* '*** - *** *, **** *** '*** - *** *, ****.
  4. *** **, **** : ******** **** ***** ** ******** ** ********.
  5. *** **, **** : ******** **** ***** ** ******** ******** ** **** ********.
  6. *** **, **** : ********** *** ********* ***** *** ***** ***** *** ***** ** ********* *** *** *****.
  7. *** **, **** : ********* ****** *** ***** ******** *** *** *** *********.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.